Genprex, Inc. (GNPX): Price and Financial Metrics
GNPX Price/Volume Stats
| Current price | $0.27 | 52-week high | $3.97 |
| Prev. close | $0.28 | 52-week low | $0.22 |
| Day low | $0.27 | Volume | 735,200 |
| Day high | $0.29 | Avg. volume | 3,176,351 |
| 50-day MA | $0.28 | Dividend yield | N/A |
| 200-day MA | $0.67 | Market Cap | 7.59M |
GNPX Stock Price Chart Interactive Chart >
Genprex, Inc. (GNPX) Company Bio
Genprex, Inc., a clinical stage gene therapy company, develops drugs to treat cancer. Its lead product candidate is Oncoprex, an active anti-cancer agent that is in Phase II clinical trials for the treatment of non-small cell lung cancer (NSCLC). It also conducts preclinical research for developing Oncoprex to be administered with immunotherapies in NSCLC; and research into other tumor suppressor genes associated with chromosome. The company was founded in 2009 and is based in Austin, Texas.
GNPX Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
GNPX Price Returns
| 1-mo | -3.57% |
| 3-mo | -20.59% |
| 6-mo | -74.04% |
| 1-year | -90.13% |
| 3-year | -99.54% |
| 5-year | -99.78% |
| YTD | -68.29% |
| 2024 | -90.74% |
| 2023 | -84.14% |
| 2022 | 10.69% |
| 2021 | -68.43% |
| 2020 | 1,196.88% |